David Lally

David Lally

Company: New England Retina Associates

Job title: Vitreoretinal Surgeon & Clinical Investigator


Evaluating the Unmet Clinical Need & Limitations of Therapeutics Targeting Angiogenesis-Driven Diseases, Neovascular/wet Age-Related Macular Degeneration (AMD) & Diabetic Macular Edema (DME) 8:15 am

VEGF agents—Bevacizumab, Ranibizumab, Brolucizumab and Aflibercept—now represent the standard of care. However, despite their proven efficacy, anti-VEGF agents still face issues such as high treatment burden due to their short duration of action This session will asses the treatment burden of existing therapies and other limitations. As well as an in-depth evaluation of the novel…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.